Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Hypertension. 2010 Nov 15;57(1):94–102. doi: 10.1161/HYPERTENSIONAHA.110.160242

Figure 1. Circulating and placental VEGF levels are decreased in BPH/5.

Figure 1

A) Summary of circulating free VEGF as determined by ELISA in non-pregnant (NP) and at early and mid-gestation C57 and BPH/5 (n=4-6 per group). B) Summary of real-time qPCR analysis of placental Vegf mRNA levels at different days of gestation (n=5 per group). Data are expressed relative to C57 at e9.5 C) Representative Western blot of VEGF protein levels in placenta samples from C57 (C) and BPH/5 (B) at early and mid-gestation. β-actin served as loading control. D) Summary of Western blot quantification (n=3 per group at each time-point) normalized to actin and expressed relative to C57 early. *p<0.05 vs NP in matched strain; †p<0.05 vs. time-matched C57.